(
A) Cells were treated with I-CBP112 for 6 hr, and levels of
IRF4 were determined as in
Figure 4A. Values represent the mean of n = 3 biological replicates ± SEM. (
B) LP-1 cells were treated with a titration of CPI203 for 6 hr, and
IRF4 expression was determined by qRT-PCR and normalized to
GAPDH. Values represent the mean of n = 2 biological replicates, ± SEM. (
C) LP-1 cells were treated with DMSO, SGC-CBP30 (2.5 μM), or I-CBP112 (5 μM). Total RNA was prepared at the indicated time points and used for qRT-PCR. Expression of
IRF4 was normalized to
GAPDH and calculated relative to DMSO treated cells at each time point. Values represent the mean of n = 4 technical replicates, ± SEM. (
D) Uninduced LP-1/IRF4 cells were treated with SGC-CBP30 (2.5 μM) or I-CBP112 (5 μM) for 24 hr, and lysates were prepared for Western analysis with the indicated antibodies. (
E) LP-1 cells were treated with the indicated concentrations of SGC-CBP30 for 16 hr, and extracts were prepared for Western analysis with the indicated antibodies.